Review of palonosetron: emerging data distinguishing it as a novel 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting

By Saito Mitsue   Tsukuda Mamoru  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 1003-1014

Informa Healthcare

Access to resources Recommend Favorite

Stratified Administration of Serotonin 5-HT Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications

By Sanchez L.A.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 533-556

Adis International

Access to resources Recommend Favorite

Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT 3 receptor antagonist - a new animal model

By Ozaki A.   Sukamoto T.  

General Pharmacology, Vol. 33, Iss. 3, 1999-09 ,pp. : 283-288

Elsevier

Access to resources Recommend Favorite

5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy

By Gregory R.E.   Ettinger D.S.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 173-189

Adis International

Access to resources Recommend Favorite

Action of 5-HT 3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew)

By Sam T.S.W.   Cheng J.T.Y.   Johnston K.D.   Kan K.K.W.   Ngan M.P.   Rudd J.A.   Wai M.K.   Yeung J.H.K.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite